课题基金 / 基金详情

Identification of novel proteins that interact with trans-activation domain of transcription factors

Identification of novel proteins that interact with trans-activation domain of transcription factors
与转录因子反式激活域相互作用的新型蛋白质的鉴定
批准号:
16570139
负责人:
SUZUKI Harukazu
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

SUZUKI Harukazu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We made an expression construct that expresses VP16-fused P53 protein followed by exploration of the interaction partners (Gal4-fusion proteins) using the mammalian two-hybrid methods (M2H). We detected two significant partner candidates judging from luciferase reporter activity ; one was mdm2, a known P53 binding partner, and the other was a 17 kDa protein without known functions. We tried co-immuno-precipitation using the tagged proteins to confirm the M2H result, although we did not confirm the latter association. Because we developed a novel method for rapid in vitro pull-down assay, we applied the method for the confirmation. However, we could not confirm the latter interaction.Next we systematically explored protein-protein interactions among mouse transcription factors. For this purpose, we used approximately 1,700 mouse cDNAs for transcription factors/transcription regulation factors. The self-activation experiment showed that 14% of transcription factors have trans-activation activity as Gal4-fusion proteins, which was significantly higher than 2-3% of trans-activation activity for other proteins. We found approximately 4,000 protein-protein interactions using the M2H. The result showed that one interaction was identified per 720 trials, which was also significantly higher value than normal case (one per thousands). Generally, there are many false-positive interactions in the two-hybrid data. Therefore, we validated our result using in vitro pull-down assay described above ; the validation was successful with very high rate (90%) for the publicly known interactions, and was also partially successful (60%) for the unknown interactions. Thus we could extract the true-positive protein-protein interactions as much as possible.
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
IProtein-protein interactions of the hyperthermophilic archaeon Pyrococcus horikoshii OT3.
超嗜热古菌堀越火球菌 OT3 的蛋白质-蛋白质相互作用。
DOI: --
发表时间: 2005
期刊: Genome Biol. 6
影响因子: --
作者: [Katsura, Yasuhiro, 林秀行, T.Sasaki., M.Mizuguchi., M.Sato., M.Demura., Barrios-Rodiles M et al., Usui K et al.]
通讯作者: Usui K et al.
網羅的相互作用解析と比較ゲノム
综合相互作用分析和比较基因组学
DOI: --
发表时间: 2004
期刊: 蛋白質核酸酵素 49
影响因子: --
作者: [Sakurai, H., Takemori, Y., 金森 睦]
通讯作者: 金森 睦
DOI: --
发表时间: 2005
期刊: ゲノム情報はこう活かせ(編集 岡崎康司, 坊農秀雅)(羊土社)
影响因子: --
作者: [Suzuki H., Usui K et al., 鈴木 治和ら, 鈴木 治和]
通讯作者: 鈴木 治和
DOI: --
发表时间: 2004
期刊: 蛋白質核酸酵素 49
影响因子: --
作者: [Hashikawa, N. et al., 鈴木 治和]
通讯作者: 鈴木 治和
14
    Development of promoterome analysis platform for combinatorial drug effects
    Large-scale screening of specific promoters for target neuronal cells and its application to high-order functional analysis in brain
    国内基金
    海外基金
    信号转导分子PAK4相互作用蛋白质的筛选
    • 批准号:
      30370736
    • 项目类别:
      面上项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2003
    • 负责人:
      李丰
    • 依托单位:
    GDNF受体下游新信号传递分子的研究